Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Total Non-Current Liabilities (2016 - 2025)

Healthstream (HSTM) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $158.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 6.1% to $158.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $158.4 million, a 6.1% increase, with the full-year FY2025 number at $158.4 million, up 6.1% from a year prior.
  • Total Non-Current Liabilities was $158.4 million for Q4 2025 at Healthstream, up from $148.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $164.9 million in Q1 2023 to a low of $145.4 million in Q3 2024.
  • A 5-year average of $153.9 million and a median of $151.5 million in 2021 define the central range for Total Non-Current Liabilities.
  • Biggest YoY gain for Total Non-Current Liabilities was 11.61% in 2021; the steepest drop was 10.84% in 2021.
  • Healthstream's Total Non-Current Liabilities stood at $146.3 million in 2021, then increased by 10.4% to $161.5 million in 2022, then decreased by 2.82% to $156.9 million in 2023, then fell by 4.84% to $149.3 million in 2024, then grew by 6.1% to $158.4 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Total Non-Current Liabilities are $158.4 million (Q4 2025), $148.7 million (Q3 2025), and $147.6 million (Q2 2025).